top of page

German Breast Cancer Center

About

Breast cancer is the most common malignancy among women, with current estimates indicating that one in eight women will be diagnosed with the disease during their lifetime. While breast cancer predominantly affects women, it can also occur in men, albeit at a significantly lower rate. In Cyprus, approximately 700 new cases are diagnosed annually, making breast cancer the second most frequently occurring cancer in the country.

It is now well-established that patients treated in dedicated Breast Centers by interdisciplinary teams achieve the best clinical outcomes. The European Parliament recognized this by declaring, more than two decades ago, that every woman has the right to high-quality prevention, treatment, and follow-up care for breast cancer.

A Multidisciplinary and Personalized Approach

At the GMI Breast Cancer Center, breast malignancies are managed by a comprehensive team of specialists representing all relevant medical disciplines. Each patient receives an individualized treatment plan, ensuring care is personalized, coordinated, and aligned with their specific clinical and personal needs.

Thanks to advances in molecular biology and biotechnology, we now have a deeper understanding of the mechanisms involved in the development and progression of breast cancer at the molecular level. This scientific progress enables:

  • Improved primary and secondary prevention strategies

  • Accurate diagnostic categorization and prognostic classification

  • The implementation of modern targeted therapies with greater precision and fewer side effects

Our patient-centered approach ensures that care is delivered safely, effectively, and with the highest standards of quality, while respecting each patient’s preferences and dignity.

Aligned with Europe’s Vision for Cancer Care

In accordance with the European Commission’s Beating Cancer Plan, the GMI Breast Cancer Center embraces a holistic model for cancer care. Our approach is grounded in:

  • Cutting-edge technologies

  • Innovative research

  • Tailored treatment pathways

We are committed to strengthening our effectiveness and resilience in the fight against cancer. At GMI, our patients never face cancer alone—we are by their side throughout the entire journey, offering expertise, compassion, and hope.


Departments Involved

Main Departments

General Surgery

Plastic Surgery

German Diagnostic Center

Radiation Oncology

Medical Oncology


Cooperative Departments

German Internal Medicine Center

German Center of Patient Support



Why Choose the GMI:

International studies consistently show that breast cancer patients treated at organized Breast Centers—such as the GMI Breast Cancer Center—experience the best clinical outcomes. Coordinated, specialist-led care within a dedicated center offers numerous advantages that directly benefit patients throughout every stage of their cancer journey:

Key Benefits of a Dedicated Breast Center:

  • Centralized, coordinated care with seamless access to all necessary specialists

  • Reduced stress and uncertainty due to shorter waiting times for appointments, diagnostic results, biopsies, and treatment initiation

  • Faster response to complications or challenges that may arise during the course of treatment

  • A patient-centered environment that fosters trust, reassurance, and emotional support

  • Minimization of unnecessary procedures by eliminating duplicate tests or visits

  • Access to advanced therapies and technology, including personalized treatment plans and clinical trials

  • Improved survival rates and reduced treatment-related morbidity

  • Lower psychological burden and faster reintegration into daily life and society

Our Multidisciplinary Team

At the GMI Breast Cancer Center, every patient benefits from the expertise of a comprehensive, multidisciplinary team, working together to deliver personalized and integrated care.

Breast Radiodiagnostics

Expert radiologists utilize advanced imaging technologies, including mammography, breast ultrasound, and MRI, to ensure early and accurate detection of abnormalities.

Breast Surgery

Our breast surgeons are highly specialized in all aspects of breast pathology and are experienced in a full range of procedures—from lumpectomies and mastectomies to advanced breast-conserving and oncoplastic techniques. The goal is always to achieve both oncological safety and aesthetically favorable outcomes.

Medical Oncology

Our oncology team is trained in the latest systemic treatments for breast cancer, including chemotherapy, immunotherapy, and targeted therapies. Each treatment plan is customized based on the molecular and genetic profile of the tumor, maximizing effectiveness while minimizing side effects.

Breast Radiotherapy

We provide precision radiotherapy tailored to each patient’s clinical needs, using the most advanced planning systems to ensure effective treatment while protecting healthy tissue.

Pathological Anatomy

Our pathology team plays a key role in diagnosis and prognosis, analyzing tissue samples at a microscopic and molecular level to guide treatment decisions.

Nuclear Medicine

The department offers sentinel lymph node detection using state-of-the-art radioisotope methods, the gold standard in early-stage breast cancer surgery. PET/CT imaging is also available for accurate staging and monitoring.

Physiotherapy & Rehabilitation / Integrative Medicine

Supportive therapies aimed at recovery, physical strength, and holistic well-being are available to aid post-treatment healing and quality of life.

Psychological & Patient Support Services

Specialized support is available to help patients and families cope emotionally and mentally, from diagnosis through treatment and beyond.

At the GMI Breast Cancer Center, we are committed to providing comprehensive, compassionate, and cutting-edge care to every patient. Your journey is our mission—and we are with you every step of the way.



FAQ

Which are the risk factors of developing breast cancer?

Breast cancer is a multifactorial disease. We are aware of numerous risk factors for its development, both genetic and environmental. Factors like age, ethnicity, gender, and heredity are non-modifiable risk factors, meaning they are factors a person cannot change or influence. However, there are also modifiable factors, which we can potentially mitigate through appropriate behavioural adjustments, such as managing our body weight, quitting smoking, and increasing physical activity. It is crucial to note that the presence of risk factors does not necessarily mean a woman will develop breast cancer. However, awareness that one belongs to a higher risk group leads to increased diligence in undergoing preventative checks, which are demonstrably the most powerful defence when facing the disease.

What are benign breast diseases?

  • Brest cysts, which are the most common finding in premenopausal women, are hormonally driven. Essentially, they are localized fluid collections within the breast. Breast cysts have a smooth texture, are movable, and can sometimes be painful. They often affect both breasts and can be found at any location. Due to their hormonal cause, cysts typically regress (disappear) during menopause unless the woman is taking oestrogen. Most cases of cysts are clinically insignificant and do not require further intervention. However, based on indications and imaging findings, your doctor may recommend further investigation (e.g., evacuative paracentesis for fluid culture or cytology, or cyst wall biopsy).

 

  • Fibroadenoma is the most common benign, solid breast tumour. It is hormone-dependent and primarily occurs in young women, although it can appear at any age. Fibroadenomas are highly mobile under the skin, firm-elastic, and well-defined. In 10-15% of cases, there are multiple fibroadenomas. Once a tumour is confirmed as a fibroadenoma (e.g., through characteristic imaging findings or a prior biopsy confirming the diagnosis), its removal is not necessary unless desired by the patient. While fibroadenomas do not turn malignant, they require monitoring at a frequency determined by your doctor. In cases where the fibroadenoma becomes painful, causes aesthetic concerns, or when there is doubt about its diagnosis, surgical removal may be recommended through a simple procedure that does not harm the breast.

 

  • Mastalgia is characterized by pain in one or both breasts, and it typically does not signify a serious health risk. Often, it is linked to hormonal fluctuations during a woman’s menstrual cycle (cyclical mastalgia) or, if not cyclic, may be associated with musculoskeletal or other issues. However, if the pain is intense and persistent, seeking medical advice is recommended.

 

  • This term encompasses a variety of histopathological changes in the breast gland and is not indicative of a disease. It describes areas in the breast that appear denser in clinical and imaging examinations. Breasts affected by fibrocystic changes can swell and become painful, varying with hormone levels, and often feel like detectable lumps. Monitoring these changes can be challenging due to their nature, but they generally are not a cause for concern.

 

  • Mastitis, an inflammation of the breast, often occurs in breastfeeding women due to blocked milk ducts, which leads to milk accumulation and bacterial growth. It can also develop outside of breastfeeding, caused by bacterial entry through the nipple’s pores or minor abrasions. Mastitis rarely relates to breast cancer and is more frequent in smokers and diabetic women. It is usually managed with broad-spectrum antibiotics, and the drainage of breast milk is necessary in breastfeeding-related cases. A breast abscess, a complication of mastitis, is a pus collection within the breast gland which requires prompt drainage. Post-inflammation imaging tests are advised to rule out the rare chance of inflammatory breast cancer.

 

  • Approximately 2% of women have inverted nipples, meaning the nipple retracts inward, potentially affecting one or both breasts. This condition can stem from developmental anomalies during embryonic growth or genetic factors. It poses cosmetic concerns and potential breastfeeding difficulties. Surgical correction is available for congenital inverted nipples, preserving the milk ducts. If an inverted nipple develops later in life, it may signal breast disease, including cancer, and should be promptly evaluated by a medical professional.

 

  • Nipple discharge can occur in one or both breasts, originating from one or several pores, and may be spontaneous or induced. If you notice discharge outside of pregnancy and breastfeeding periods, a medical consultation is recommended. The discharge might be due to a benign tumour within a breast duct, medication side effects, thyroid or pituitary gland disorders, or less commonly, breast cancer.

 

  • This type of tumour, which arises outside the milk ducts, is known for its rapid growth and propensity for recurrence. Suspected phyllodes tumours should be surgically removed to prevent malignant transformation. Due to its rapid size increase, reconstructive surgery might be necessary for complete removal and to maintain cosmetic appearance.

 

  • Gynecomastia is defined as excessive growth of the male breast gland, resulting in enlargement not caused by obesity-related fat accumulation. It is the most prevalent male breast condition and often has hormonal origins. In adolescents (ages 12-15), it typically results from an imbalance of oestradiol and testosterone and usually resolves with maturity. Adult onset, especially if unilateral, warrants medical evaluation. The doctor will investigate potential causes, including specific medications or supplements, and rule out neoplastic conditions. Idiopathic gynecomastia, without an identifiable cause, can be surgically addressed for cosmetic reasons, often through a safe and aesthetically pleasing subcutaneous mastectomy.


bottom of page